RXULTI 1mg film-coated tablets OTSUKA
brexpiprazol Indicated for: schizophrenia; bipolar disorder
N05AX16 Nervous system | Antipsychotics | Other antipsychotics
letter R · page 60
brexpiprazol Indicated for: schizophrenia; bipolar disorder
N05AX16 Nervous system | Antipsychotics | Other antipsychotics
brexpiprazol Indicated for: schizophrenia; bipolar disorder
N05AX16 Nervous system | Antipsychotics | Other antipsychotics
brexpiprazol Indicated for: schizophrenia; bipolar disorder
N05AX16 Nervous system | Antipsychotics | Other antipsychotics
brexpiprazol Indicated for: schizophrenia; bipolar disorder
N05AX16 Nervous system | Antipsychotics | Other antipsychotics
olopatadine + mometasone Indicated for: allergic rhinitis
semaglutide Indicated for: type 2 diabetes mellitus; weight management
semaglutide Indicated for: type 2 diabetes mellitus; weight management
semaglutide Indicated for: type 2 diabetes mellitus; weight management
semaglutide Indicated for: type 2 diabetes mellitus; weight management
semaglutide Indicated for: type 2 diabetes mellitus; weight management
semaglutide Indicated for: type 2 diabetes mellitus; weight management
amivantamab Indicated for: non-small cell lung cancer
amivantamab Indicated for: non-small cell lung cancer
amivantamab Indicated for: non-small cell lung cancer
amivantamab Indicated for: non-small cell lung cancer
amivantamab Indicated for: non-small cell lung cancer
midostaurin Indicated for: acute myeloid leukemia; systemic mastocytosis
relugolix + estradiol + norethisterone Indicated for: menopausal symptoms
human alfa-1 proteinase inhibitor Indicated for: alpha-1 antitrypsin deficiency
B02AB02 Blood and blood forming organs | Antifibrinolytics | Proteinase inhibitors
human alfa-1 proteinase inhibitor Indicated for: alpha-1 antitrypsin deficiency
B02AB02 Blood and blood forming organs | Antifibrinolytics | Proteinase inhibitors